Group Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons Centres
- Conditions
- Alzheimer's Disease
- Interventions
- Behavioral: Psychotherapy groupsBehavioral: Self-help groups
- Registration Number
- NCT02418806
- Lead Sponsor
- Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
- Brief Summary
An experimental study designed to test the effectiveness of a psychological intervention based on group therapy for the caregivers of Alzheimer's disease patients. The intervention consists of 16 sessions of a cognitive-behavioral psychological group therapy. This study aims to demonstrate that Alzheimer's patients' caregivers can decrease the feelings of burden after been involved in a group therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 231
- Main caregiver of an Alzheimer Disease Patient.
- Alzheimer Disease Patient with mild/severe cognitive impairment.
- High compliance to therapy sessions.
- Sign informed consent.
- Low commitment to develop all study phases.
- Caregiver activity remunerated.
- Caregiver with psychiatric disorders that can affect the development of the sessions.
- Caregivers who have received psychological care during last year.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Therapy group without follow up sessions Psychotherapy groups Weekly psychotherapy groups during 4 months Active comparator group Self-help groups Weekly self-help groups during 4 months with a monthly follow up period (12 months) Therapy group with follow up sessions Psychotherapy groups Weekly psychotherapy groups during 4 months with a monthly follow up period (12 months)
- Primary Outcome Measures
Name Time Method Efficacy of group therapy in caregiver burden measured by Zarit Burden Interview. 16 months
- Secondary Outcome Measures
Name Time Method Change in resilience from baseline compared to the control and active arms measured by Connor-Davidson Resilience Scale. 4 months - 16 months Change in caregiver burden from baseline compared to the control and active arms measured by Zarit Burden Interview. 4 months and 16 months Change in anxiety and depression from baseline compared to the control and active arms measured by Goldberg Scale. 4 months and 16 months Descriptive analysis of the caregivers' characteristics (sociodemographics, relation wih the AD patient). Baseline (0 months) Preliminary cost-effectiveness analysis related resources needed to caregivers and Alzheimer patients. 4 months - 16 months Change in quality of life from baseline compared to the control and active arms measured by Casp-19 and SF-36 questionnaires. 4 months - 16 months Change in functional social support from baseline compared to the control and active arms using Duke-UNC questionnaire. 4 months - 16 months Descriptive analysis of the caregiver's cognition using DEM-DETECT Module 1. 4 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (11)
AFA Burgos
🇪🇸Burgos, Spain
AFA Castellón
🇪🇸Castellón, Spain
AFA Lleida
🇪🇸Lleida, Spain
AFA Barcelona
🇪🇸Barcelona, Spain
Centro de envejecimiento saludable
🇪🇸Málaga, Spain
AFA Terres de l'Ebre
🇪🇸Tortosa, Spain
Centro de día Vitalia
🇪🇸Barcelona, Spain
AVAN
🇪🇸Sabadell, Spain
AGUAFA
🇪🇸Guadasuar, Spain
AFATE
🇪🇸Tenerife, Spain
Fundació Ana Ribot
🇪🇸Pallejà, Spain